GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » Accounts Payable & Accrued Expense

X Bioscience PCL (BKK:XBIO-W7) Accounts Payable & Accrued Expense : ฿158.6 Mil (As of Mar. 2025)


View and export this data going back to 2025. Start your Free Trial

What is X Bioscience PCL Accounts Payable & Accrued Expense?

X Bioscience PCL's quarterly accounts payable & accrued expense increased from Sep. 2024 (฿125.7 Mil) to Dec. 2024 (฿150.1 Mil) and increased from Dec. 2024 (฿150.1 Mil) to Mar. 2025 (฿158.6 Mil).

X Bioscience PCL's annual accounts payable & accrued expense increased from Dec. 2022 (฿86.0 Mil) to Dec. 2023 (฿101.6 Mil) and increased from Dec. 2023 (฿101.6 Mil) to Dec. 2024 (฿150.1 Mil).

X Bioscience PCL Accounts Payable & Accrued Expense Historical Data

The historical data trend for X Bioscience PCL's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

X Bioscience PCL Accounts Payable & Accrued Expense Chart

X Bioscience PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 66.31 115.94 85.95 101.58 150.08

X Bioscience PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.76 117.12 125.67 150.08 158.59

X Bioscience PCL Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

X Bioscience PCL Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Retail - Defensive » X Bioscience PCL (BKK:XBIO-W7) » Definitions » Accounts Payable & Accrued Expense
Comparable Companies
BKK:KK SYY USFD XLIS:JMT PFGC LSE:BNZL JSE:BID BKK:CPAXT ASX:MTS SGX:VC2 CHEF HAM:B4B XKRX:026960 ADX:GHITHA TSE:7451 SZSE:000061 WAR:KER UNFI XKRX:006040 ANDE
Traded in Other Exchanges
XBIO:Thailand
Address
Phahon Yothin Road, No.304, Room No.1803-1806, 18th Floor, Vanit Place Aree Tower (Tower A, Sam Sen Nai, Bangkok, THA, 10400
Website
https://www.xbio.co.th
X Bioscience PCL is engaged in investment in food and beverages business and the group are engaged in selling food and beverages, and manufacturing and selling biological products. The group operates in two business segments: the food and beverage sales segment and the internal management services segment provided by the parent company. The group operates in a single geographic area, which is Thailand. The company's brand consists of Kagonaya, Bake, and Leboeuf.

X Bioscience PCL Headlines

No Headlines